Vilazodone hydrochloride 10 MG Oral Tablet — RxCUI 1086772
RxNorm drug concept · Semantic clinical drug
RxCUI 1086772
Semantic clinical drug · SCD
● Current RxNorm concept 33 FDA products
51 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1086772
Official nameVilazodone hydrochloride 10 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asvilazodone HCl 10 MG Oral Tablet
FDA products mapped33
Package NDCs mapped51
Reported Medicaid activity (SDUD)285,554 prescriptions · 50 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Vilazodone: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Vilazodone — brand name Viibryd — is an antidepressant approved to treat major depressive disorder (MDD) in adults. MDD is a clinical condition, not just ordinary sadness, and it c...
- Yes, this one genuinely matters. If you take vilazodone without food, your body may absorb up to 50% less of the drug — which could make it significantly less effective. Try to tak...
- Does it really matter if I take it with food?
- The most common ones are digestive: diarrhea, nausea, and sometimes vomiting — especially in the first few weeks. Insomnia, headache, and dizziness are also possible. These often i...
🕸️ Concept Web — How Vilazodone hydrochloride 10 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Vilazodone hydrochloride 10 MG Oral Tablet
RxCUI 1086772 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Vilazodone
1086769IN -
Vilazodone hydrochloride
1086768PIN
-
Vilazodone
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Viibryd
1086773BN
-
Viibryd
-
Dose forms 13
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Vilazodone Oral Tablet
1086771SCDF -
Vilazodone hydrochloride Oral Tablet
2647066SCDFP -
Vilazodone Oral Product
1164578SCDG -
Vilazodone Pill
1164579SCDG -
Vilazodone hydrochloride Oral Product
2662525SCDGP -
Vilazodone hydrochloride Pill
2663052SCDGP -
Vilazodone Oral Tablet [Viibryd]
1086775SBDF -
Vilazodone hydrochloride Oral Tablet [Viibryd]
2655108SBDFP - +5 more in this family
-
Vilazodone Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Vilazodone hydrochloride 10 MG
1086770SCDC -
Vilazodone hydrochloride 10 MG Oral Tablet [Viibryd]
1086776SBD -
Vilazodone hydrochloride 10 MG [Viibryd]
1086774SBDC
-
Vilazodone hydrochloride 10 MG
Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Vilazodone hydrochloride 10 MG
SCDC · 1086770 -
Vilazodone Oral Tablet
SCDF · 1086771 -
Vilazodone hydrochloride Oral Tablet
SCDFP · 2647066 -
Vilazodone Oral Product
SCDG · 1164578 -
Vilazodone Pill
SCDG · 1164579 -
Vilazodone hydrochloride Oral Product
SCDGP · 2662525 -
Vilazodone hydrochloride Pill
SCDGP · 2663052
Brand-Name Concepts
-
Vilazodone hydrochloride 10 MG Oral Tablet [Viibryd]
SBD · 1086776 -
Vilazodone hydrochloride 10 MG [Viibryd]
SBDC · 1086774 -
Vilazodone Oral Tablet [Viibryd]
SBDF · 1086775 -
Vilazodone hydrochloride Oral Tablet [Viibryd]
SBDFP · 2655108 -
Viibryd Oral Product
SBDG · 1186600 -
Viibryd Pill
SBDG · 1186601 -
Viibryd
BN · 1086773
📦 FDA Products & Package NDCs
33 products · 51 package NDCs
51 package NDCs map to RxCUI 1086772 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00456-1110-30 | 30 TABLET in 1 BOTTLE (0456-1110-30) | VIIBRYD | Allergan, Inc. | 2011-04-29 |
| 00456-1120-30 | 30 TABLET in 1 BOTTLE (0456-1120-30) | VIIBRYD | Allergan, Inc. | 2011-04-29 |
| 00456-1140-30 | 30 TABLET in 1 BOTTLE (0456-1140-30) | VIIBRYD | Allergan, Inc. | 2011-04-29 |
| 00480-2043-56 | 30 TABLET, FILM COATED in 1 BOTTLE (0480-2043-56) | Vilazodone Hydrochloride | Teva Pharmaceuticals, Inc. | 2022-06-06 |
| 00480-2044-56 | 30 TABLET, FILM COATED in 1 BOTTLE (0480-2044-56) | Vilazodone Hydrochloride | Teva Pharmaceuticals, Inc. | 2022-06-06 |
| 00480-2045-56 | 30 TABLET, FILM COATED in 1 BOTTLE (0480-2045-56) | Vilazodone Hydrochloride | Teva Pharmaceuticals, Inc. | 2022-06-06 |
| 16729-0352-10 | 30 TABLET in 1 BOTTLE (16729-352-10) | Vilazodone Hydrochloride | Accord Healthcare Inc. | 2022-06-04 |
| 16729-0353-10 | 30 TABLET in 1 BOTTLE (16729-353-10) | Vilazodone Hydrochloride | Accord Healthcare Inc. | 2022-06-04 |
| 16729-0354-10 | 30 TABLET in 1 BOTTLE (16729-354-10) | Vilazodone Hydrochloride | Accord Healthcare Inc. | 2022-06-04 |
| 46708-0232-30 | 30 TABLET, FILM COATED in 1 BOTTLE (46708-232-30) | VILAZODONE HYDROCHLORIDE | Alembic Pharmaceuticals Limited | 2022-06-04 |
| 46708-0232-71 | 500 TABLET, FILM COATED in 1 BOTTLE (46708-232-71) | VILAZODONE HYDROCHLORIDE | Alembic Pharmaceuticals Limited | 2022-06-04 |
| 46708-0232-90 | 90 TABLET, FILM COATED in 1 BOTTLE (46708-232-90) | VILAZODONE HYDROCHLORIDE | Alembic Pharmaceuticals Limited | 2022-06-04 |
| 46708-0232-91 | 1000 TABLET, FILM COATED in 1 BOTTLE (46708-232-91) | VILAZODONE HYDROCHLORIDE | Alembic Pharmaceuticals Limited | 2022-06-04 |
| 46708-0233-30 | 30 TABLET, FILM COATED in 1 BOTTLE (46708-233-30) | VILAZODONE HYDROCHLORIDE | Alembic Pharmaceuticals Limited | 2022-06-04 |
| 46708-0233-71 | 500 TABLET, FILM COATED in 1 BOTTLE (46708-233-71) | VILAZODONE HYDROCHLORIDE | Alembic Pharmaceuticals Limited | 2022-06-04 |
| 46708-0233-90 | 90 TABLET, FILM COATED in 1 BOTTLE (46708-233-90) | VILAZODONE HYDROCHLORIDE | Alembic Pharmaceuticals Limited | 2022-06-04 |
| 46708-0233-91 | 1000 TABLET, FILM COATED in 1 BOTTLE (46708-233-91) | VILAZODONE HYDROCHLORIDE | Alembic Pharmaceuticals Limited | 2022-06-04 |
| 46708-0234-30 | 30 TABLET, FILM COATED in 1 BOTTLE (46708-234-30) | VILAZODONE HYDROCHLORIDE | Alembic Pharmaceuticals Limited | 2022-06-04 |
| 46708-0234-71 | 500 TABLET, FILM COATED in 1 BOTTLE (46708-234-71) | VILAZODONE HYDROCHLORIDE | Alembic Pharmaceuticals Limited | 2022-06-04 |
| 46708-0234-90 | 90 TABLET, FILM COATED in 1 BOTTLE (46708-234-90) | VILAZODONE HYDROCHLORIDE | Alembic Pharmaceuticals Limited | 2022-06-04 |
| 46708-0234-91 | 1000 TABLET, FILM COATED in 1 BOTTLE (46708-234-91) | VILAZODONE HYDROCHLORIDE | Alembic Pharmaceuticals Limited | 2022-06-04 |
| 51407-0915-30 | 30 TABLET, FILM COATED in 1 BOTTLE (51407-915-30) | Vilazodone Hydrochloride | Golden State Medical Supply, Inc. | 2025-05-27 |
| 51407-0916-30 | 30 TABLET, FILM COATED in 1 BOTTLE (51407-916-30) | Vilazodone Hydrochloride | Golden State Medical Supply, Inc. | 2025-05-27 |
| 51407-0917-30 | 30 TABLET, FILM COATED in 1 BOTTLE (51407-917-30) | Vilazodone Hydrochloride | Golden State Medical Supply, Inc. | 2025-05-27 |
| 60505-4372-03 | 30 TABLET in 1 BOTTLE (60505-4372-3) | vilazodone hydrochloride | Apotex Corp. | 2023-10-26 |
| 60505-4373-03 | 30 TABLET in 1 BOTTLE (60505-4373-3) | vilazodone hydrochloride | Apotex Corp. | 2023-10-26 |
| 60505-4374-03 | 30 TABLET in 1 BOTTLE (60505-4374-3) | vilazodone hydrochloride | Apotex Corp. | 2023-10-26 |
| 62332-0232-30 | 30 TABLET, FILM COATED in 1 BOTTLE (62332-232-30) | VILAZODONE HYDROCHLORIDE | Alembic Pharmaceuticals Inc. | 2022-06-04 |
| 62332-0232-71 | 500 TABLET, FILM COATED in 1 BOTTLE (62332-232-71) | VILAZODONE HYDROCHLORIDE | Alembic Pharmaceuticals Inc. | 2022-06-04 |
| 62332-0232-90 | 90 TABLET, FILM COATED in 1 BOTTLE (62332-232-90) | VILAZODONE HYDROCHLORIDE | Alembic Pharmaceuticals Inc. | 2022-06-04 |
| 62332-0232-91 | 1000 TABLET, FILM COATED in 1 BOTTLE (62332-232-91) | VILAZODONE HYDROCHLORIDE | Alembic Pharmaceuticals Inc. | 2022-06-04 |
| 62332-0233-30 | 30 TABLET, FILM COATED in 1 BOTTLE (62332-233-30) | VILAZODONE HYDROCHLORIDE | Alembic Pharmaceuticals Inc. | 2022-06-04 |
| 62332-0233-71 | 500 TABLET, FILM COATED in 1 BOTTLE (62332-233-71) | VILAZODONE HYDROCHLORIDE | Alembic Pharmaceuticals Inc. | 2022-06-04 |
| 62332-0233-90 | 90 TABLET, FILM COATED in 1 BOTTLE (62332-233-90) | VILAZODONE HYDROCHLORIDE | Alembic Pharmaceuticals Inc. | 2022-06-04 |
| 62332-0233-91 | 1000 TABLET, FILM COATED in 1 BOTTLE (62332-233-91) | VILAZODONE HYDROCHLORIDE | Alembic Pharmaceuticals Inc. | 2022-06-04 |
| 62332-0234-30 | 30 TABLET, FILM COATED in 1 BOTTLE (62332-234-30) | VILAZODONE HYDROCHLORIDE | Alembic Pharmaceuticals Inc. | 2022-06-04 |
| 62332-0234-71 | 500 TABLET, FILM COATED in 1 BOTTLE (62332-234-71) | VILAZODONE HYDROCHLORIDE | Alembic Pharmaceuticals Inc. | 2022-06-04 |
| 62332-0234-90 | 90 TABLET, FILM COATED in 1 BOTTLE (62332-234-90) | VILAZODONE HYDROCHLORIDE | Alembic Pharmaceuticals Inc. | 2022-06-04 |
| 62332-0234-91 | 1000 TABLET, FILM COATED in 1 BOTTLE (62332-234-91) | VILAZODONE HYDROCHLORIDE | Alembic Pharmaceuticals Inc. | 2022-06-04 |
| 69097-0979-02 | 30 TABLET, FILM COATED in 1 BOTTLE (69097-979-02) | Vilazodone Hydrochloride | Cipla USA Inc. | 2023-01-23 |
| 69097-0981-02 | 30 TABLET, FILM COATED in 1 BOTTLE (69097-981-02) | Vilazodone hydrochloride | Cipla USA Inc. | 2023-01-23 |
| 69097-0982-02 | 30 TABLET, FILM COATED in 1 BOTTLE (69097-982-02) | Vilazodone hydrochloride | Cipla USA Inc. | 2023-01-23 |
| 72205-0260-30 | 30 TABLET in 1 BOTTLE (72205-260-30) | vilazodone hydrochloride | Novadoz Pharmaceuticals LLC | 2023-07-14 |
| 72205-0261-30 | 30 TABLET in 1 BOTTLE (72205-261-30) | vilazodone hydrochloride | Novadoz Pharmaceuticals LLC | 2023-07-14 |
| 72205-0262-30 | 30 TABLET in 1 BOTTLE (72205-262-30) | vilazodone hydrochloride | Novadoz Pharmaceuticals LLC | 2023-07-14 |
| 72603-0813-01 | 30 TABLET in 1 BOTTLE (72603-813-01) | vilazodone hydrochloride | Northstar Rx LLC | 2025-01-01 |
| 72603-0814-01 | 30 TABLET in 1 BOTTLE (72603-814-01) | vilazodone hydrochloride | Northstar Rx LLC | 2025-01-01 |
| 72603-0815-01 | 30 TABLET in 1 BOTTLE (72603-815-01) | vilazodone hydrochloride | Northstar Rx LLC | 2025-01-01 |
| 76282-0544-30 | 30 TABLET, FILM COATED in 1 BOTTLE (76282-544-30) | Vilazodone Hydrochloride | Exelan Pharmaceuticals Inc. | 2022-12-01 |
| 76282-0545-30 | 30 TABLET, FILM COATED in 1 BOTTLE (76282-545-30) | Vilazodone hydrochloride | Exelan Pharmaceuticals Inc. | 2022-12-01 |
Observed labelers:
Alembic Pharmaceuticals Inc. (12) ·
Alembic Pharmaceuticals Limited (12) ·
Accord Healthcare Inc. (3) ·
Allergan, Inc. (3) ·
Apotex Corp. (3) ·
Cipla USA Inc. (3)
· +5 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.